Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.

Pharmacogenomics - 1 Jul 2011

Nyberg Fredrik, Barratt Bryan J, Mushiroda Taisei, Takahashi Atsushi, Jawaid Ansar, Hada Shuji, Umemura Takaaki, Fukuoka Masahiro, Nakata Koichiro, Ohe Yuichiro, Kato Harubumi, Kudoh Shoji, March Ruth, Nakamura Yusuke, Kamatani Naoyuki

Abstract excerpt

AIM: To investigate potential relationships between SNPs and acute interstitial lung disease (ILD) events in Japanese non-small-cell lung cancer patients receiving gefitinib. MATERIALS & METHODS: Japanese non-small-cell lung cancer patients treated with gefitinib from a prospective pharmacoepidemiological cohort with a nested case-control study component ('CCS'; 52 ILD cases, 139 controls) and a retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gefitinib

Share to Genome-Wide Association Study

Share to Lung Diseases, Interstitial

Share to Lung Neoplasms

Share to Quinazolines

Source

Identifiers

PMID: 21787189
DOI: 10.2217/pgs.11.38

Genes

CCS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.PMID 21787189Read ↗

Proteomic biomarkers for acute interstitial lung disease in gefitinib-treated Japanese lung cancer patients.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study.Semantic proximity Read ↗

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung diseaseSemantic proximity Read ↗

Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405).Semantic proximity Read ↗

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.Semantic proximity Read ↗

Genetic variants of JNK and p38α pathways and risk of non-small cell lung cancer in an Eastern Chinese population.Semantic proximity Read ↗

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.Semantic proximity Read ↗

Genetic Association of Curative and Adverse Reactions to Tyrosine Kinase Inhibitors in Chinese advanced Non-Small Cell Lung Cancer patients.Semantic proximity Read ↗

Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.Semantic proximity Read ↗

Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse EventsSemantic proximity Read ↗

Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival.Semantic proximity Read ↗

Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in Japan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.